About 20/20 GeneSystems
20/20 GeneSystems is a private company based in Gaithersburg, Maryland. It has reported $4,583,413 raised in three offerings on Form D since September 2015. Its chief executive is Jonathan Cohen.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | Feb 26, 2025 | $70,000of $3.0M target | 3 | $23,333 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jan 28, 2016 | Feb 4, 2016 | $2,000,000of $3.0M target | 1 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Oct 31, 2014 | Sep 22, 2015amended Feb 19, 2016 | $2,513,413of $4.0M target | 66 | $38,082 | Equity, Options, Securities on exerciseRule 506(c) | Form D/A ↗2 earlier filings |
| Total, three offerings | $4,583,413 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on 20/20 GeneSystems's Form D filed Feb 26, 2025.
JC
Jonathan Cohen
President & CEO, director
PR
Prasanth Reddy
Director
JC
John Compton
Director
JR
John Rollins
Director
WL
Wei Lu
Director
RC
Richard Cohen
Director
AS
Anne Shiflett
Executive officer
JZ
Jiminy Zhou
Executive officer
MR
Michael Ross
Director
Earlier filings also listed Vladimir Knezevic (director, last listed Feb 2016), Joel Kanter (executive officer and director, last listed Feb 2016), Donald Wallach (director, last listed Feb 2016), Dean Hautamaki (director, last listed Feb 2016) and Caroline Popper (director, last listed Feb 2016).